2021
DOI: 10.1021/acs.orglett.1c03435
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of N-Fused Triazole–Piperazine–Quinazolinones via One-Pot Tandem Click Reaction and Cross-Dehydrogenative Coupling

Abstract: Herein, a one-pot protocol to synthesize tetracyclic triazole−piperazine−quinazolinone-fused N-heterocyclic scaffolds is reported. In this strategy, a tandem approach of two highly efficient synthetic reactions, click and cross-dehydrogentive coupling reactions, with high atom economy were employed to obtain the target N-fused scaffolds. Being highly functional group tolerable, this method has broad substrate scope. Interestingly, some of these derivatives showed strong white solid-state fluorescence.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 41 publications
0
10
0
Order By: Relevance
“…Various intermolecular condensations are found in the literature for the effective generation of diversified axially chiral biaryl-bridged seven-membered fused azepinones . Synthesis of several polyheterocycle-fused isoquinolinone and quinazolinone derivatives, mostly through transition-metal-catalyzed cyclization reactions are also reported . However, generation of fused heterocycles through the ring expansion of carbocyclic scaffolds by 1,2-migration of C–C σ-bond is limited due to difficulties in the cleavage of C–C bond .…”
Section: Introductionmentioning
confidence: 99%
“…Various intermolecular condensations are found in the literature for the effective generation of diversified axially chiral biaryl-bridged seven-membered fused azepinones . Synthesis of several polyheterocycle-fused isoquinolinone and quinazolinone derivatives, mostly through transition-metal-catalyzed cyclization reactions are also reported . However, generation of fused heterocycles through the ring expansion of carbocyclic scaffolds by 1,2-migration of C–C σ-bond is limited due to difficulties in the cleavage of C–C bond .…”
Section: Introductionmentioning
confidence: 99%
“…The fabrication of polycyclic heterocycles can be achieved via metal-catalyzed intramolecular cross-dehydrogenative coupling reactions between heterocycles and heterocycle-linked arenes/heteroarenes. 7–9 Although synthetically very attractive, this protocol suffers from the disadvantage of step-wise construction of both heterocycles linked with an aliphatic chain. 7,8 Additionally, the intermolecular 9 dehydrogenative cross-coupling has been well studied to date, and intramolecular variants have remained limited.…”
mentioning
confidence: 99%
“…2 Fewer cases exist in which the α-position is occupied by an alternative to the carbonyl group (e.g., ardeemin 5 10 and evodiamine analog 6 11 ), though synthetic method development is more frequently producing these modified frameworks to explore potential pharmacology, as seen with scaffold 7. 12 Recently, we reported a route to diastereomeric pyrrolopyrazinoquinazolinones (Figure 2a). 13 In that work, a Ugi−Mumm/aza-Wittig protocol generated densely functionalized quinazolinones that underwent a tandem quinazolinone rearrangement/intramolecular amidine ring closure.…”
mentioning
confidence: 99%
“…Dihydropyrazino-[2,1- b ]-quinazolinones, which feature a 4­(3 H )-quinazolinone fused to a piperidine ring (Figure , highlighted core), are a ubiquitous subclass of fungal metabolites in which the piperidinyl nitrogen atom is often flanked by a carbonyl and at least one alkyl appendage on the α- and α′-carbons, respectively ( 1 – 4 , Figure ). Fewer cases exist in which the α-position is occupied by an alternative to the carbonyl group (e.g., ardeemin 5 and evodiamine analog 6 ), though synthetic method development is more frequently producing these modified frameworks to explore potential pharmacology, as seen with scaffold 7 …”
mentioning
confidence: 99%